

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | replicative senescence (GO:0090399) | 6.20329223 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.74092263 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.74092263 |
| 4 | mannose metabolic process (GO:0006013) | 4.73740638 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.63001947 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 4.63001947 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 4.57860034 |
| 8 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.56051296 |
| 9 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.28550849 |
| 10 | behavioral response to nicotine (GO:0035095) | 4.20495130 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 4.16803370 |
| 12 | positive regulation of CREB transcription factor activity (GO:0032793) | 4.09545888 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.05176360 |
| 14 | tryptophan catabolic process (GO:0006569) | 3.81680978 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 3.81680978 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.81680978 |
| 17 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72118440 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.64872146 |
| 19 | tryptophan metabolic process (GO:0006568) | 3.54799451 |
| 20 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.52622934 |
| 21 | response to pheromone (GO:0019236) | 3.50699055 |
| 22 | biotin metabolic process (GO:0006768) | 3.50223348 |
| 23 | negative T cell selection (GO:0043383) | 3.46290781 |
| 24 | thymic T cell selection (GO:0045061) | 3.43849522 |
| 25 | kynurenine metabolic process (GO:0070189) | 3.41932007 |
| 26 | cellular response to exogenous dsRNA (GO:0071360) | 3.40802166 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35558204 |
| 28 | urea metabolic process (GO:0019627) | 3.34527832 |
| 29 | urea cycle (GO:0000050) | 3.34527832 |
| 30 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.32844721 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 3.30711399 |
| 32 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.30508208 |
| 33 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.30508208 |
| 34 | intestinal absorption (GO:0050892) | 3.30322169 |
| 35 | phospholipid efflux (GO:0033700) | 3.29793697 |
| 36 | positive thymic T cell selection (GO:0045059) | 3.29285898 |
| 37 | nucleotide transmembrane transport (GO:1901679) | 3.28712114 |
| 38 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.27421022 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.25305815 |
| 40 | alpha-linolenic acid metabolic process (GO:0036109) | 3.24984304 |
| 41 | positive regulation of defense response to virus by host (GO:0002230) | 3.23513102 |
| 42 | positive regulation of histone deacetylation (GO:0031065) | 3.21555189 |
| 43 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.20951083 |
| 44 | cholesterol efflux (GO:0033344) | 3.20819301 |
| 45 | L-fucose catabolic process (GO:0042355) | 3.16660678 |
| 46 | fucose catabolic process (GO:0019317) | 3.16660678 |
| 47 | L-fucose metabolic process (GO:0042354) | 3.16660678 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.16216187 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.16216187 |
| 50 | carnitine shuttle (GO:0006853) | 3.15701993 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.15600940 |
| 52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15166928 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 3.14502911 |
| 54 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.12516224 |
| 55 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.12516224 |
| 56 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.12030591 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 3.11434598 |
| 58 | amine catabolic process (GO:0009310) | 3.11434598 |
| 59 | negative regulation of cell killing (GO:0031342) | 3.09613450 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09613450 |
| 61 | hormone catabolic process (GO:0042447) | 3.04170565 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.03846301 |
| 63 | fucosylation (GO:0036065) | 3.03539058 |
| 64 | bile acid biosynthetic process (GO:0006699) | 3.01255807 |
| 65 | activated T cell proliferation (GO:0050798) | 3.00734222 |
| 66 | T cell selection (GO:0045058) | 2.99010758 |
| 67 | positive regulation of protein kinase C signaling (GO:0090037) | 2.98184901 |
| 68 | tolerance induction (GO:0002507) | 2.97189137 |
| 69 | negative regulation of sterol transport (GO:0032372) | 2.94061206 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 2.94061206 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.93586330 |
| 72 | positive regulation of cholesterol efflux (GO:0010875) | 2.92587640 |
| 73 | semaphorin-plexin signaling pathway (GO:0071526) | 2.92512750 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92225543 |
| 75 | phospholipid homeostasis (GO:0055091) | 2.91268992 |
| 76 | lipoprotein metabolic process (GO:0042157) | 2.91241810 |
| 77 | NAD biosynthetic process (GO:0009435) | 2.89770175 |
| 78 | positive T cell selection (GO:0043368) | 2.87945265 |
| 79 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87339250 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 2.86749064 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 2.85446124 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 2.85308683 |
| 83 | energy homeostasis (GO:0097009) | 2.85253667 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84174291 |
| 85 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.82957261 |
| 86 | bile acid metabolic process (GO:0008206) | 2.82176116 |
| 87 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.80615882 |
| 88 | fatty acid beta-oxidation (GO:0006635) | 2.79062277 |
| 89 | carnitine metabolic process (GO:0009437) | 2.78737781 |
| 90 | nitrogen cycle metabolic process (GO:0071941) | 2.78636210 |
| 91 | cellular response to ATP (GO:0071318) | 2.76912038 |
| 92 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.76852432 |
| 93 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.76130039 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 2.75816400 |
| 95 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.75623932 |
| 96 | fatty acid transmembrane transport (GO:1902001) | 2.75376803 |
| 97 | intracellular lipid transport (GO:0032365) | 2.74722523 |
| 98 | positive regulation of cholesterol transport (GO:0032376) | 2.72166075 |
| 99 | positive regulation of sterol transport (GO:0032373) | 2.72166075 |
| 100 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.72033768 |
| 101 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72014354 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 2.72014354 |
| 103 | macromolecular complex remodeling (GO:0034367) | 2.72014354 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71743257 |
| 105 | telomere maintenance via telomerase (GO:0007004) | 2.71248585 |
| 106 | fatty acid oxidation (GO:0019395) | 2.71241122 |
| 107 | regulation of triglyceride catabolic process (GO:0010896) | 2.70504906 |
| 108 | cellular anion homeostasis (GO:0030002) | 2.70163153 |
| 109 | serine family amino acid catabolic process (GO:0009071) | 2.69097739 |
| 110 | regulation of lipoprotein particle clearance (GO:0010984) | 2.69071479 |
| 111 | lipid oxidation (GO:0034440) | 2.68503172 |
| 112 | drug catabolic process (GO:0042737) | 2.68384631 |
| 113 | cholesterol homeostasis (GO:0042632) | 2.67675525 |
| 114 | histone H3-K4 trimethylation (GO:0080182) | 2.67256756 |
| 115 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.66948082 |
| 116 | macroautophagy (GO:0016236) | 2.64250761 |
| 117 | glyoxylate metabolic process (GO:0046487) | 2.63580788 |
| 118 | vitamin transmembrane transport (GO:0035461) | 2.59712555 |
| 119 | urinary tract smooth muscle contraction (GO:0014848) | 2.59266186 |
| 120 | sterol homeostasis (GO:0055092) | 2.59175151 |
| 121 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58727987 |
| 122 | regulation of interleukin-8 secretion (GO:2000482) | 2.58576556 |
| 123 | DNA deamination (GO:0045006) | 2.57817873 |
| 124 | coenzyme catabolic process (GO:0009109) | 2.57768236 |
| 125 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.57526718 |
| 126 | cellular glucuronidation (GO:0052695) | 2.56351025 |
| 127 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.55613917 |
| 128 | regulation of triglyceride metabolic process (GO:0090207) | 2.54916117 |
| 129 | linoleic acid metabolic process (GO:0043651) | 2.54426718 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53872006 |
| 131 | histone H3-K4 methylation (GO:0051568) | 2.52304202 |
| 132 | regulation of hippo signaling (GO:0035330) | 2.51565613 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 2.50757473 |
| 134 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.50424312 |
| 135 | positive regulation of protein homooligomerization (GO:0032464) | 2.50358606 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.50355749 |
| 137 | plasma lipoprotein particle organization (GO:0071827) | 2.50292049 |
| 138 | histone H4-K12 acetylation (GO:0043983) | 2.49552589 |
| 139 | homocysteine metabolic process (GO:0050667) | 2.48271266 |
| 140 | 2-oxoglutarate metabolic process (GO:0006103) | 2.47439463 |
| 141 | regulation of synapse maturation (GO:0090128) | 2.45770646 |
| 142 | regulation of defense response to virus by host (GO:0050691) | 2.45706358 |
| 143 | regulation of histone deacetylation (GO:0031063) | 2.45536274 |
| 144 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.44755504 |
| 145 | regulation of hypersensitivity (GO:0002883) | 2.44565185 |
| 146 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43426842 |
| 147 | protein targeting to lysosome (GO:0006622) | 2.43007500 |
| 148 | establishment of protein localization to vacuole (GO:0072666) | 2.43007500 |
| 149 | protein targeting to vacuole (GO:0006623) | 2.43007500 |
| 150 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.41932790 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 2.41603374 |
| 152 | negative regulation of telomere maintenance (GO:0032205) | 2.38623251 |
| 153 | regulation of ARF GTPase activity (GO:0032312) | 2.35630407 |
| 154 | histone H3-K9 modification (GO:0061647) | 2.35148975 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.34577451 |
| 156 | cardiolipin metabolic process (GO:0032048) | 2.34556917 |
| 157 | N-glycan processing (GO:0006491) | 2.34078542 |
| 158 | positive regulation of protein deacetylation (GO:0090312) | 2.33428681 |
| 159 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.33117660 |
| 160 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.30993374 |
| 161 | histone H3-K9 methylation (GO:0051567) | 2.29493005 |
| 162 | negative regulation of mast cell activation (GO:0033004) | 2.29298339 |
| 163 | lytic vacuole organization (GO:0080171) | 2.28898386 |
| 164 | lysosome organization (GO:0007040) | 2.28898386 |
| 165 | nephron epithelium morphogenesis (GO:0072088) | 2.26614867 |
| 166 | nephron tubule morphogenesis (GO:0072078) | 2.26614867 |
| 167 | cell migration in hindbrain (GO:0021535) | 2.23438620 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.20863633 |
| 169 | regulation of cilium assembly (GO:1902017) | 2.19277019 |
| 170 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.18475771 |
| 171 | hemidesmosome assembly (GO:0031581) | 2.18251136 |
| 172 | response to muramyl dipeptide (GO:0032495) | 2.17910971 |
| 173 | regulation of antigen processing and presentation (GO:0002577) | 2.16665220 |
| 174 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.14319996 |
| 175 | N-acetylneuraminate metabolic process (GO:0006054) | 2.13921722 |
| 176 | positive regulation of Rab GTPase activity (GO:0032851) | 2.13080996 |
| 177 | regulation of Rab GTPase activity (GO:0032313) | 2.13080996 |
| 178 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.11837886 |
| 179 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.11656871 |
| 180 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.11656871 |
| 181 | negative regulation of T cell mediated immunity (GO:0002710) | 2.10975191 |
| 182 | glycine transport (GO:0015816) | 2.10739786 |
| 183 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.10673665 |
| 184 | mitochondrion transport along microtubule (GO:0047497) | 2.10673665 |
| 185 | fucose metabolic process (GO:0006004) | 2.10247722 |
| 186 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.08576802 |
| 187 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.08463439 |
| 188 | interferon-gamma production (GO:0032609) | 2.06629293 |
| 189 | opioid receptor signaling pathway (GO:0038003) | 2.06298845 |
| 190 | RNA destabilization (GO:0050779) | 2.04382321 |
| 191 | gamma-aminobutyric acid transport (GO:0015812) | 2.04063128 |
| 192 | negative regulation of macroautophagy (GO:0016242) | 2.03421002 |
| 193 | positive regulation of synapse maturation (GO:0090129) | 2.02834628 |
| 194 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.00300999 |
| 195 | basic amino acid transport (GO:0015802) | 1.99947112 |
| 196 | regulation of mast cell activation (GO:0033003) | 1.99734528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.77593482 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48113864 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.41724247 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09132131 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.52547816 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.32863591 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.19392150 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.11768488 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.01707799 |
| 10 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.87830913 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70232133 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61332268 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.48158786 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.45268194 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43351761 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21474552 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19896956 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.16716651 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.02578303 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00958504 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96544637 |
| 22 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.95899321 |
| 23 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.85237146 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83754002 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79021354 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73035101 |
| 27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69949928 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69696329 |
| 29 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62911474 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62251354 |
| 31 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.58292959 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57928813 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51987659 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.51233248 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50497763 |
| 36 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.48229676 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47817550 |
| 38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45523933 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44312542 |
| 40 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.42525408 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42517667 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38230363 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37609183 |
| 44 | ERA_21632823_ChIP-Seq_H3396_Human | 1.37107634 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36255379 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36055344 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35369696 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33288842 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33046017 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32513594 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32390877 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.32290320 |
| 53 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.32161150 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31898029 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31164822 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29963290 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28335698 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28221420 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27699462 |
| 60 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.27509783 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27407496 |
| 62 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.26798891 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.26721249 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26316654 |
| 65 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25772492 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.25572933 |
| 67 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23102663 |
| 68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22612896 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22348652 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21928033 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19188273 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18885449 |
| 73 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18151748 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18013506 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17918345 |
| 76 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17625039 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15183520 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14669479 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14661817 |
| 80 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14406520 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14224661 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14222486 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14162792 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14051285 |
| 85 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.13386885 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13063408 |
| 87 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.11093569 |
| 88 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.09809554 |
| 89 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08589049 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08406136 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07357101 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06615295 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05560846 |
| 94 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.05402267 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 1.04620398 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03817564 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03671676 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03343972 |
| 99 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02931107 |
| 100 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02122186 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.01869011 |
| 102 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01021165 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00989840 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00117530 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99923349 |
| 106 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99365555 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98981635 |
| 108 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98750081 |
| 109 | MYC_22102868_ChIP-Seq_BL_Human | 0.98376770 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98163832 |
| 111 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98096528 |
| 112 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97767338 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97685542 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97470470 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96947447 |
| 116 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.96887652 |
| 117 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.96483938 |
| 118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.96381247 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95436773 |
| 120 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95343192 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93676960 |
| 122 | P68_20966046_ChIP-Seq_HELA_Human | 0.92487685 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92472966 |
| 124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91616684 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.91036968 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88127234 |
| 127 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86988404 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85961167 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85139431 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.84184473 |
| 131 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83880597 |
| 132 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83761720 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81680264 |
| 134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80453374 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78727073 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78499004 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78424509 |
| 138 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78136071 |
| 139 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.78089080 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77350577 |
| 141 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75660092 |
| 142 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.75435073 |
| 143 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75296440 |
| 144 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73269546 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73214770 |
| 146 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.71992064 |
| 147 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71232593 |
| 148 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70667656 |
| 149 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69724915 |
| 150 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.69183826 |
| 151 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.68397315 |
| 152 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.68002299 |
| 153 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67786191 |
| 154 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.67341455 |
| 155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67218377 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66838676 |
| 157 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.66705577 |
| 158 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66645363 |
| 159 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.66026162 |
| 160 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.64914038 |
| 161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.63728556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.31580776 |
| 2 | MP0005365_abnormal_bile_salt | 5.15078195 |
| 3 | MP0005360_urolithiasis | 5.09345304 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.93741764 |
| 5 | MP0003252_abnormal_bile_duct | 3.84460401 |
| 6 | MP0002254_reproductive_system_inflammat | 3.51928939 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.07730631 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.99543122 |
| 9 | MP0005670_abnormal_white_adipose | 2.92926609 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88319169 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.71809421 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.55685739 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.54292823 |
| 14 | MP0004858_abnormal_nervous_system | 2.26872064 |
| 15 | MP0000685_abnormal_immune_system | 2.24772213 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.18561390 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.14183035 |
| 18 | MP0002933_joint_inflammation | 2.00679558 |
| 19 | MP0009840_abnormal_foam_cell | 1.97212746 |
| 20 | MP0001800_abnormal_humoral_immune | 1.96372674 |
| 21 | MP0009384_cardiac_valve_regurgitation | 1.93523341 |
| 22 | MP0000013_abnormal_adipose_tissue | 1.88951714 |
| 23 | MP0004381_abnormal_hair_follicle | 1.85511109 |
| 24 | MP0001348_abnormal_lacrimal_gland | 1.84946267 |
| 25 | MP0003724_increased_susceptibility_to | 1.83791613 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.82370255 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.80061134 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.78891992 |
| 29 | MP0000609_abnormal_liver_physiology | 1.78835127 |
| 30 | MP0003868_abnormal_feces_composition | 1.71370639 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.68165392 |
| 32 | MP0004142_abnormal_muscle_tone | 1.62290074 |
| 33 | MP0004130_abnormal_muscle_cell | 1.61460225 |
| 34 | MP0008961_abnormal_basal_metabolism | 1.59547261 |
| 35 | MP0005332_abnormal_amino_acid | 1.58222750 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.57758948 |
| 37 | MP0002723_abnormal_immune_serum | 1.56662868 |
| 38 | MP0003866_abnormal_defecation | 1.56282924 |
| 39 | MP0005377_hearing/vestibular/ear_phenot | 1.51858504 |
| 40 | MP0003878_abnormal_ear_physiology | 1.51858504 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.51822541 |
| 42 | MP0001663_abnormal_digestive_system | 1.50130013 |
| 43 | MP0005025_abnormal_response_to | 1.49235705 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.49221615 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.48670443 |
| 46 | MP0002419_abnormal_innate_immunity | 1.47489860 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.45328398 |
| 48 | MP0001873_stomach_inflammation | 1.44793057 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.44191802 |
| 50 | MP0004947_skin_inflammation | 1.43742079 |
| 51 | MP0002928_abnormal_bile_duct | 1.43372679 |
| 52 | MP0005083_abnormal_biliary_tract | 1.41445400 |
| 53 | MP0000003_abnormal_adipose_tissue | 1.40320157 |
| 54 | MP0000538_abnormal_urinary_bladder | 1.39938339 |
| 55 | MP0003195_calcinosis | 1.37465494 |
| 56 | MP0001764_abnormal_homeostasis | 1.37412580 |
| 57 | MP0001270_distended_abdomen | 1.36846823 |
| 58 | MP0001819_abnormal_immune_cell | 1.36729257 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.36702912 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.36440483 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.36227119 |
| 62 | MP0005647_abnormal_sex_gland | 1.33984062 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.31347880 |
| 64 | MP0003279_aneurysm | 1.28377525 |
| 65 | MP0005451_abnormal_body_composition | 1.23520033 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.23354711 |
| 67 | MP0003329_amyloid_beta_deposits | 1.23302421 |
| 68 | MP0002405_respiratory_system_inflammati | 1.20786954 |
| 69 | MP0003303_peritoneal_inflammation | 1.20478816 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.19809920 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.19360210 |
| 72 | MP0001849_ear_inflammation | 1.18515052 |
| 73 | MP0009697_abnormal_copulation | 1.18344806 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.17129428 |
| 75 | MP0009764_decreased_sensitivity_to | 1.15796656 |
| 76 | MP0003283_abnormal_digestive_organ | 1.15084825 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.13464520 |
| 78 | MP0005381_digestive/alimentary_phenotyp | 1.13418120 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.13230251 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.11739329 |
| 81 | MP0001984_abnormal_olfaction | 1.11031949 |
| 82 | MP0001765_abnormal_ion_homeostasis | 1.09766249 |
| 83 | MP0001958_emphysema | 1.08635371 |
| 84 | MP0005171_absent_coat_pigmentation | 1.07185946 |
| 85 | MP0000604_amyloidosis | 1.06409340 |
| 86 | MP0002009_preneoplasia | 1.06128924 |
| 87 | MP0003136_yellow_coat_color | 1.05056078 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 1.03071335 |
| 89 | MP0001968_abnormal_touch/_nociception | 1.02759535 |
| 90 | MP0005409_darkened_coat_color | 1.02172642 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 1.01641189 |
| 92 | MP0003646_muscle_fatigue | 1.01181886 |
| 93 | MP0008260_abnormal_autophagy | 1.00979382 |
| 94 | MP0000470_abnormal_stomach_morphology | 0.99843600 |
| 95 | MP0005499_abnormal_olfactory_system | 0.97607658 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.97607658 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.97297503 |
| 98 | MP0004043_abnormal_pH_regulation | 0.96927798 |
| 99 | MP0000716_abnormal_immune_system | 0.96080205 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.94464167 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.94229080 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.94020916 |
| 103 | MP0009785_altered_susceptibility_to | 0.93223198 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.93000505 |
| 105 | MP0000371_diluted_coat_color | 0.92280892 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.91652503 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.90795639 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.90094399 |
| 109 | MP0005310_abnormal_salivary_gland | 0.88933981 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.88350677 |
| 111 | MP0004133_heterotaxia | 0.88164329 |
| 112 | MP0005646_abnormal_pituitary_gland | 0.87448986 |
| 113 | MP0002075_abnormal_coat/hair_pigmentati | 0.87094654 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.84587839 |
| 115 | MP0003045_fibrosis | 0.83944254 |
| 116 | MP0005448_abnormal_energy_balance | 0.83197775 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.82570243 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.82535568 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.82503505 |
| 120 | MP0006054_spinal_hemorrhage | 0.82350928 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.81620044 |
| 122 | MP0005423_abnormal_somatic_nervous | 0.81416126 |
| 123 | MP0008469_abnormal_protein_level | 0.80610774 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.80358833 |
| 125 | MP0003787_abnormal_imprinting | 0.80213864 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.78809255 |
| 127 | MP0009763_increased_sensitivity_to | 0.78309004 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.77517073 |
| 129 | MP0004147_increased_porphyrin_level | 0.76270441 |
| 130 | MP0001835_abnormal_antigen_presentation | 0.74698875 |
| 131 | MP0001970_abnormal_pain_threshold | 0.74076550 |
| 132 | MP0004885_abnormal_endolymph | 0.73997510 |
| 133 | MP0009278_abnormal_bone_marrow | 0.73717174 |
| 134 | MP0000598_abnormal_liver_morphology | 0.73316306 |
| 135 | MP0005334_abnormal_fat_pad | 0.72236000 |
| 136 | MP0001661_extended_life_span | 0.72213390 |
| 137 | MP0003953_abnormal_hormone_level | 0.71333751 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.70711767 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70387123 |
| 140 | MP0002229_neurodegeneration | 0.69374006 |
| 141 | MP0002429_abnormal_blood_cell | 0.68698653 |
| 142 | MP0005387_immune_system_phenotype | 0.68656405 |
| 143 | MP0001790_abnormal_immune_system | 0.68656405 |
| 144 | MP0000613_abnormal_salivary_gland | 0.66905245 |
| 145 | MP0002132_abnormal_respiratory_system | 0.66471633 |
| 146 | MP0010155_abnormal_intestine_physiology | 0.65559784 |
| 147 | MP0006082_CNS_inflammation | 0.63174055 |
| 148 | MP0000383_abnormal_hair_follicle | 0.62728660 |
| 149 | MP0008789_abnormal_olfactory_epithelium | 0.60792744 |
| 150 | MP0002822_catalepsy | 0.58480134 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.57002006 |
| 152 | MP0005671_abnormal_response_to | 0.56980538 |
| 153 | MP0005367_renal/urinary_system_phenotyp | 0.55957353 |
| 154 | MP0000516_abnormal_urinary_system | 0.55957353 |
| 155 | MP0003436_decreased_susceptibility_to | 0.54448884 |
| 156 | MP0001756_abnormal_urination | 0.54445630 |
| 157 | MP0002971_abnormal_brown_adipose | 0.53705368 |
| 158 | MP0001324_abnormal_eye_pigmentation | 0.51854333 |
| 159 | MP0003172_abnormal_lysosome_physiology | 0.51263498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.06506034 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 3.85881619 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58730847 |
| 4 | Hyperglycinuria (HP:0003108) | 3.49424880 |
| 5 | Chronic hepatic failure (HP:0100626) | 3.40523870 |
| 6 | Pustule (HP:0200039) | 3.27312336 |
| 7 | Hemorrhage of the eye (HP:0011885) | 3.22512082 |
| 8 | Congenital stationary night blindness (HP:0007642) | 3.12649443 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.10601239 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.06608460 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04177409 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94181969 |
| 13 | Hypoglycemic coma (HP:0001325) | 2.92500953 |
| 14 | Generalized hyperpigmentation (HP:0007440) | 2.89743063 |
| 15 | Symptomatic seizures (HP:0011145) | 2.88578081 |
| 16 | Type II lissencephaly (HP:0007260) | 2.86746544 |
| 17 | Ketosis (HP:0001946) | 2.84856083 |
| 18 | Thin bony cortex (HP:0002753) | 2.84831095 |
| 19 | Abnormal biliary tract physiology (HP:0012439) | 2.84502519 |
| 20 | Bile duct proliferation (HP:0001408) | 2.84502519 |
| 21 | Renal cortical cysts (HP:0000803) | 2.79651879 |
| 22 | Joint hemorrhage (HP:0005261) | 2.78094708 |
| 23 | Clumsiness (HP:0002312) | 2.76510716 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74932653 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.71563714 |
| 26 | Mucopolysacchariduria (HP:0008155) | 2.71153122 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71153122 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70715216 |
| 29 | Ketoacidosis (HP:0001993) | 2.70111283 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67615760 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67615760 |
| 32 | Genetic anticipation (HP:0003743) | 2.64779614 |
| 33 | Abnormal pancreas size (HP:0012094) | 2.60981823 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.56298838 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.56298838 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.55231723 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 2.53856054 |
| 38 | Myositis (HP:0100614) | 2.53477239 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52562159 |
| 40 | Enlarged kidneys (HP:0000105) | 2.51803057 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.50859581 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.50859581 |
| 43 | Xanthomatosis (HP:0000991) | 2.46819641 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.45191957 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.44529096 |
| 46 | Cervical subluxation (HP:0003308) | 2.44034426 |
| 47 | Hyperglycemia (HP:0003074) | 2.40580585 |
| 48 | Keratoconus (HP:0000563) | 2.39608203 |
| 49 | Increased corneal curvature (HP:0100692) | 2.39608203 |
| 50 | Anal stenosis (HP:0002025) | 2.37656666 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 2.37576332 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36336301 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.36259436 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.35334345 |
| 55 | Fat malabsorption (HP:0002630) | 2.31912015 |
| 56 | Deep venous thrombosis (HP:0002625) | 2.31645823 |
| 57 | Hyperglycinemia (HP:0002154) | 2.30741604 |
| 58 | Confusion (HP:0001289) | 2.29985379 |
| 59 | Stomatitis (HP:0010280) | 2.29358366 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29077669 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29077669 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29077669 |
| 63 | Congenital hepatic fibrosis (HP:0002612) | 2.28941165 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 2.28324024 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28021886 |
| 66 | Abnormality of DNA repair (HP:0003254) | 2.26850317 |
| 67 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25898236 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.24410302 |
| 69 | Lissencephaly (HP:0001339) | 2.23341820 |
| 70 | Gingival bleeding (HP:0000225) | 2.22023684 |
| 71 | J-shaped sella turcica (HP:0002680) | 2.18874533 |
| 72 | Joint stiffness (HP:0001387) | 2.18338680 |
| 73 | Colitis (HP:0002583) | 2.17853209 |
| 74 | Hyperammonemia (HP:0001987) | 2.16263696 |
| 75 | Entropion (HP:0000621) | 2.15159943 |
| 76 | Status epilepticus (HP:0002133) | 2.15049916 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.14715323 |
| 78 | Severe muscular hypotonia (HP:0006829) | 2.12357499 |
| 79 | Pseudobulbar signs (HP:0002200) | 2.12040582 |
| 80 | Hypercholesterolemia (HP:0003124) | 2.11957532 |
| 81 | Central scotoma (HP:0000603) | 2.11953990 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 2.11906734 |
| 83 | Optic neuritis (HP:0100653) | 2.11906734 |
| 84 | Nephronophthisis (HP:0000090) | 2.11732102 |
| 85 | Epidermoid cyst (HP:0200040) | 2.11283537 |
| 86 | Anterior segment dysgenesis (HP:0007700) | 2.11036272 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10893347 |
| 88 | Hypobetalipoproteinemia (HP:0003563) | 2.10131352 |
| 89 | Protruding tongue (HP:0010808) | 2.08287445 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.06903233 |
| 91 | Hypochromic anemia (HP:0001931) | 2.06683214 |
| 92 | Progressive sensorineural hearing impairment (HP:0000408) | 2.06175413 |
| 93 | Intestinal atresia (HP:0011100) | 2.06042953 |
| 94 | Disproportionate short-trunk short stature (HP:0003521) | 2.04118166 |
| 95 | Orchitis (HP:0100796) | 2.02897746 |
| 96 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02189340 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.02150621 |
| 98 | Hemiplegia (HP:0002301) | 2.01619451 |
| 99 | Hyperacusis (HP:0010780) | 2.00605695 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00096654 |
| 101 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00096654 |
| 102 | Agitation (HP:0000713) | 1.99199700 |
| 103 | Febrile seizures (HP:0002373) | 1.97869224 |
| 104 | Malnutrition (HP:0004395) | 1.96800399 |
| 105 | Hypoalphalipoproteinemia (HP:0003233) | 1.96751067 |
| 106 | Rough bone trabeculation (HP:0100670) | 1.96128719 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94885655 |
| 108 | Cheilitis (HP:0100825) | 1.92236067 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 1.91288357 |
| 110 | Abnormality of purine metabolism (HP:0004352) | 1.91233813 |
| 111 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.90618762 |
| 112 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.89682029 |
| 113 | Metabolic acidosis (HP:0001942) | 1.89538305 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88139664 |
| 115 | Annular pancreas (HP:0001734) | 1.87429657 |
| 116 | Increased IgM level (HP:0003496) | 1.87001676 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 1.85945537 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 1.85055988 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85055988 |
| 120 | Hypolipoproteinemia (HP:0010981) | 1.84763374 |
| 121 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84348639 |
| 122 | Decreased central vision (HP:0007663) | 1.83198659 |
| 123 | Cystic liver disease (HP:0006706) | 1.82847386 |
| 124 | Enlarged epiphyses (HP:0010580) | 1.82623228 |
| 125 | IgG deficiency (HP:0004315) | 1.82051692 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.80999575 |
| 127 | Tetraplegia (HP:0002445) | 1.80917747 |
| 128 | Abnormality of the renal medulla (HP:0100957) | 1.80721693 |
| 129 | Poikiloderma (HP:0001029) | 1.79140699 |
| 130 | Keratitis (HP:0000491) | 1.79045895 |
| 131 | Retinal dysplasia (HP:0007973) | 1.78922711 |
| 132 | Type I transferrin isoform profile (HP:0003642) | 1.78632857 |
| 133 | Melanoma (HP:0002861) | 1.78140818 |
| 134 | Myocardial infarction (HP:0001658) | 1.78010904 |
| 135 | Vacuolated lymphocytes (HP:0001922) | 1.77971799 |
| 136 | Abnormality of the fingertips (HP:0001211) | 1.77940300 |
| 137 | Atrophic scars (HP:0001075) | 1.77830149 |
| 138 | Abnormality of macrophages (HP:0004311) | 1.76573506 |
| 139 | Stridor (HP:0010307) | 1.76530978 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.75372845 |
| 141 | Gastrointestinal infarctions (HP:0005244) | 1.74514215 |
| 142 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74244987 |
| 143 | Pancreatic cysts (HP:0001737) | 1.74218222 |
| 144 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.74215272 |
| 145 | Sensorimotor neuropathy (HP:0007141) | 1.74139440 |
| 146 | Inflammation of the large intestine (HP:0002037) | 1.73760437 |
| 147 | Progressive cerebellar ataxia (HP:0002073) | 1.73522215 |
| 148 | Stomach cancer (HP:0012126) | 1.73350296 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.72510171 |
| 150 | Pendular nystagmus (HP:0012043) | 1.71962865 |
| 151 | Hemoptysis (HP:0002105) | 1.71489134 |
| 152 | Flat capital femoral epiphysis (HP:0003370) | 1.70852376 |
| 153 | Opisthotonus (HP:0002179) | 1.70602548 |
| 154 | Hypoplasia of the brainstem (HP:0002365) | 1.69198248 |
| 155 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.69198248 |
| 156 | Cortical visual impairment (HP:0100704) | 1.68951240 |
| 157 | Gout (HP:0001997) | 1.68447192 |
| 158 | Hypoplasia of the fovea (HP:0007750) | 1.68245348 |
| 159 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68245348 |
| 160 | Optic nerve coloboma (HP:0000588) | 1.67837312 |
| 161 | Abnormality of the hepatic vasculature (HP:0006707) | 1.67542107 |
| 162 | Bulbous nose (HP:0000414) | 1.67341808 |
| 163 | Pigmentary retinal degeneration (HP:0001146) | 1.67161775 |
| 164 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.66150629 |
| 165 | Retinal atrophy (HP:0001105) | 1.66094259 |
| 166 | Hypochromic microcytic anemia (HP:0004840) | 1.65196394 |
| 167 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.64790840 |
| 168 | Epileptic encephalopathy (HP:0200134) | 1.64504147 |
| 169 | Large eyes (HP:0001090) | 1.64385582 |
| 170 | True hermaphroditism (HP:0010459) | 1.64251285 |
| 171 | Esophageal varix (HP:0002040) | 1.64236128 |
| 172 | Prolonged neonatal jaundice (HP:0006579) | 1.64118768 |
| 173 | Abnormality of the columella (HP:0009929) | 1.63923171 |
| 174 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.63623912 |
| 175 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63599552 |
| 176 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63599552 |
| 177 | Milia (HP:0001056) | 1.63260909 |
| 178 | Persistence of primary teeth (HP:0006335) | 1.63226385 |
| 179 | Ectropion (HP:0000656) | 1.63168771 |
| 180 | Rectal prolapse (HP:0002035) | 1.62496080 |
| 181 | Abnormality of the thoracic spine (HP:0100711) | 1.61677106 |
| 182 | Pulmonary infiltrates (HP:0002113) | 1.60943282 |
| 183 | Supernumerary nipples (HP:0002558) | 1.60911848 |
| 184 | Macroglossia (HP:0000158) | 1.60756723 |
| 185 | Easy fatigability (HP:0003388) | 1.60399880 |
| 186 | Long palpebral fissure (HP:0000637) | 1.60243827 |
| 187 | Patellar aplasia (HP:0006443) | 1.60163362 |
| 188 | Rib fusion (HP:0000902) | 1.58713476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.60316177 |
| 2 | INSRR | 4.09561078 |
| 3 | CDK12 | 3.24984821 |
| 4 | TLK1 | 2.99335162 |
| 5 | PRPF4B | 2.97848589 |
| 6 | AKT3 | 2.96122019 |
| 7 | BCKDK | 2.75884526 |
| 8 | BRD4 | 2.64437368 |
| 9 | TRIB3 | 2.63435902 |
| 10 | WNK4 | 2.26698491 |
| 11 | SIK1 | 2.05345344 |
| 12 | IRAK3 | 1.99624238 |
| 13 | LATS1 | 1.90533828 |
| 14 | MAP3K14 | 1.89048678 |
| 15 | MAP4K1 | 1.86896048 |
| 16 | CAMKK1 | 1.78374045 |
| 17 | ZAK | 1.77005369 |
| 18 | EPHA2 | 1.51282829 |
| 19 | GRK1 | 1.51110360 |
| 20 | SGK2 | 1.48919170 |
| 21 | CAMK1D | 1.47140402 |
| 22 | GRK6 | 1.43138356 |
| 23 | TXK | 1.37860206 |
| 24 | MAPK15 | 1.37278027 |
| 25 | NTRK2 | 1.34276002 |
| 26 | BLK | 1.33536305 |
| 27 | MAP2K6 | 1.32387492 |
| 28 | TYK2 | 1.31240752 |
| 29 | PKN2 | 1.31142888 |
| 30 | DYRK3 | 1.31069125 |
| 31 | JAK1 | 1.28735010 |
| 32 | FGFR4 | 1.28653394 |
| 33 | TIE1 | 1.26937814 |
| 34 | YES1 | 1.26553952 |
| 35 | CAMKK2 | 1.19068957 |
| 36 | ITK | 1.18335957 |
| 37 | BMPR1B | 1.15073185 |
| 38 | EPHA3 | 1.14755337 |
| 39 | SGK3 | 1.11574434 |
| 40 | TAOK3 | 1.08531769 |
| 41 | SIK2 | 1.05993507 |
| 42 | PINK1 | 1.03474121 |
| 43 | MAP2K3 | 1.02558943 |
| 44 | RIPK4 | 1.02242119 |
| 45 | CHUK | 1.00564945 |
| 46 | FRK | 1.00545439 |
| 47 | TYRO3 | 0.99202720 |
| 48 | HIPK2 | 0.98680569 |
| 49 | MAP3K11 | 0.96620704 |
| 50 | TNK2 | 0.96571825 |
| 51 | DAPK2 | 0.93295449 |
| 52 | MAPK7 | 0.92936705 |
| 53 | IKBKE | 0.92312984 |
| 54 | IRAK4 | 0.92034267 |
| 55 | MTOR | 0.91922953 |
| 56 | PRKAA1 | 0.91860224 |
| 57 | MAP3K7 | 0.89600563 |
| 58 | PRKD3 | 0.88739497 |
| 59 | NLK | 0.88498667 |
| 60 | CAMK1G | 0.88249394 |
| 61 | MAPK11 | 0.87507670 |
| 62 | PRKAA2 | 0.87399431 |
| 63 | CAMK4 | 0.87036602 |
| 64 | ICK | 0.86102515 |
| 65 | ACVR1B | 0.85992890 |
| 66 | WNK1 | 0.84205999 |
| 67 | PRKD2 | 0.83774648 |
| 68 | RPS6KA2 | 0.81999836 |
| 69 | SYK | 0.79737105 |
| 70 | FLT3 | 0.79500896 |
| 71 | RIPK1 | 0.78820086 |
| 72 | MATK | 0.76896638 |
| 73 | MAP2K2 | 0.76876164 |
| 74 | PIM2 | 0.76675954 |
| 75 | JAK3 | 0.75120384 |
| 76 | CASK | 0.72234300 |
| 77 | SGK494 | 0.72198008 |
| 78 | SGK223 | 0.72198008 |
| 79 | ADRBK1 | 0.71984213 |
| 80 | MAPK12 | 0.71896878 |
| 81 | PIK3CA | 0.71282022 |
| 82 | IKBKB | 0.71051733 |
| 83 | PASK | 0.70583863 |
| 84 | MARK3 | 0.68462177 |
| 85 | TAOK2 | 0.68038113 |
| 86 | STK38 | 0.67993539 |
| 87 | RPS6KL1 | 0.66754041 |
| 88 | RPS6KC1 | 0.66754041 |
| 89 | SIK3 | 0.65340094 |
| 90 | EEF2K | 0.63931088 |
| 91 | MUSK | 0.63093627 |
| 92 | ZAP70 | 0.62199612 |
| 93 | BTK | 0.61715151 |
| 94 | RPS6KA6 | 0.60485210 |
| 95 | BMX | 0.60269884 |
| 96 | MAP3K6 | 0.59152039 |
| 97 | CDC42BPA | 0.58868058 |
| 98 | HCK | 0.58382530 |
| 99 | RET | 0.58233531 |
| 100 | PTK2B | 0.58010320 |
| 101 | PTK6 | 0.57443153 |
| 102 | ATR | 0.56468105 |
| 103 | PDK1 | 0.56304704 |
| 104 | PDPK1 | 0.56128928 |
| 105 | PRKCQ | 0.56040364 |
| 106 | MAPK13 | 0.55873388 |
| 107 | TBK1 | 0.55121607 |
| 108 | KIT | 0.54397160 |
| 109 | TEC | 0.52912539 |
| 110 | TGFBR1 | 0.52453609 |
| 111 | MAP3K1 | 0.51653384 |
| 112 | EIF2AK2 | 0.50538496 |
| 113 | STK11 | 0.49362596 |
| 114 | CDK9 | 0.48904932 |
| 115 | EPHB1 | 0.48885183 |
| 116 | GSK3A | 0.48052760 |
| 117 | IRAK1 | 0.47772939 |
| 118 | NUAK1 | 0.47111567 |
| 119 | ERBB2 | 0.46954761 |
| 120 | NTRK1 | 0.46853013 |
| 121 | ADRBK2 | 0.46849791 |
| 122 | MARK2 | 0.46642883 |
| 123 | CSF1R | 0.46368284 |
| 124 | PTK2 | 0.45779677 |
| 125 | CSK | 0.45581965 |
| 126 | MAP3K10 | 0.45536843 |
| 127 | DYRK1A | 0.45439976 |
| 128 | DYRK1B | 0.45367719 |
| 129 | NTRK3 | 0.43870493 |
| 130 | MAPK1 | 0.41297658 |
| 131 | MAP3K13 | 0.40606287 |
| 132 | AKT1 | 0.40582118 |
| 133 | LCK | 0.39862217 |
| 134 | PRKCH | 0.39723707 |
| 135 | MAPK3 | 0.39425542 |
| 136 | CDK4 | 0.39075908 |
| 137 | PRKG1 | 0.38960223 |
| 138 | CDK3 | 0.38107209 |
| 139 | TGFBR2 | 0.37801296 |
| 140 | PRKCI | 0.36984202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.17554046 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.12738890 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74765324 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61915224 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.49344875 |
| 6 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.44159454 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42460049 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28280846 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.12766785 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02287507 |
| 11 | * ABC transporters_Homo sapiens_hsa02010 | 1.95085030 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.94916983 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.93527517 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.92744548 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.87369179 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81675145 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80391939 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80282494 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.77966278 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76082837 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64867167 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64746080 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63631202 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62807468 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61631388 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60937971 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.60834710 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60278142 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59644869 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56088679 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50998219 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.50330910 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.50163605 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.48360998 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48230214 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48084870 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46691438 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44995522 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38237276 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34828260 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32826461 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32574558 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31043163 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28878470 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28861235 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28007169 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.27833227 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27711573 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24484427 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21058582 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.20977471 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20089248 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19194308 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17067574 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13864845 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13842038 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10757738 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10610620 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08916724 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05573834 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04535111 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03276361 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02322099 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00880877 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.96904324 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.95948615 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95858613 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94705286 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94320774 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93838146 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93374479 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93266855 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92900102 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90703138 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90688990 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89989683 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.87918047 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87443334 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86022964 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84530688 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84274104 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82192948 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82077811 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81495874 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80480570 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79696193 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78912649 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77745213 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77617885 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.77110509 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76047770 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.75352151 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75292038 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75004356 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74876667 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74423290 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73292183 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.72953587 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71715688 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.70135198 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69805097 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68963636 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68757933 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68325257 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68196201 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.67629994 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65478037 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65046716 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.64411579 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64116698 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62800655 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62762665 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62252392 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.62079318 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60858214 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59283050 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.58679676 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56224277 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55988320 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55320783 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.54504517 |
| 122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54280013 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54098117 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53867287 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53771178 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53057757 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51843654 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51501383 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.51337226 |
| 130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50846610 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50589120 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50580865 |
| 133 | Measles_Homo sapiens_hsa05162 | 0.50441075 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50012778 |
| 135 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49974508 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48653067 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48123617 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.46672206 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46551668 |
| 140 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46550421 |
| 141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46447386 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44975146 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44625879 |
| 144 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43536240 |
| 145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41590564 |
| 146 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39671594 |
| 147 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38988410 |
| 148 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37514620 |
| 149 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36777792 |
| 150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36620207 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36415604 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35966044 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32981954 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30448983 |
| 155 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30252175 |
| 156 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29933083 |
| 157 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29732672 |
| 158 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29362828 |
| 159 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29334947 |
| 160 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28327418 |
| 161 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27804492 |
| 162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26164239 |
| 163 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26025501 |
| 164 | Influenza A_Homo sapiens_hsa05164 | 0.25378931 |
| 165 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25371610 |
| 166 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22934305 |

